Fundraising FoxJangoBio
Fitchburg, US · Wisconsin LLC
Find your way into JangoBio
Sign up to see every warm intro you have to JangoBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the JangoBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
JangoBio is a biotechnology company developing regenerative stem cell therapies aimed at aging and age-related diseases by restoring sex hormone balance. It builds cell-based organoids designed to regenerate or replace gonadal tissues lost during aging to increase hormone production and longevity.
Founders & leadership
Funding
SEC filings, press & company announcements$2.4M disclosed across 1 of 2 rounds · 2016–2025
- Undisclosed amountSeedMar 2025Source ↗
▶$2.4MraisedJun 2020 · 72 investors · BiotechnologyRule 506(b)
- Robert CramerDirector
- William KohlExecutive Officer, Director
- Victor MohoneyDirector
- Richard BowenDirector
- Craig S. AtwoodExecutive Officer, Director, Promoter
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- First sale
- Nov 2016
- Incorporated
- Limited Liability Company, Wisconsin
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2016 | $364.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does JangoBio do?
- JangoBio is a biotechnology company developing regenerative stem cell therapies aimed at aging and age-related diseases by restoring sex hormone balance. It builds cell-based organoids designed to regenerate or replace gonadal tissues lost during aging to increase hormone production and longevity.
- How much funding has JangoBio raised?
- JangoBio has disclosed $2.4M raised across 1 of its 2 known rounds.
- Where is JangoBio headquartered?
- JangoBio is headquartered in Fitchburg, US.